National Institute of Cancerología Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT03296553
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

National Institute of Cancerología